Differences of Atomic-Level Interactions between Midazolam and Two CYP Isoforms 3A4 and 3A5

Area of Science:

• Biochemistry
• Pharmacology
• Computational Chemistry

Background:

• Cytochrome P450 enzymes, specifically CYP 3A4 and CYP 3A5, are crucial for drug metabolism.
• Differences in their active site structures lead to variations in drug efficacy and toxicity among individuals.

Purpose of the Study:

• To investigate the binding interactions of midazolam (MDZ) with CYP 3A4 and CYP 3A5.
• To elucidate the structural basis for differential drug metabolism by these two enzyme isoforms.

Main Methods:

• Molecular dynamics (MD) simulations were employed to study the protein-substrate complexes.
• Binding free energy calculations were performed to quantify interaction stability.

Main Results:

• Both CYP 3A4 and CYP 3A5 form stable interactions with MDZ, notably via a hydrogen bond with Ser119.
• The CYP 3A4-MDZ complex demonstrated greater stability, attributed to a sandwich structure involving the substrate's fluorophenyl group and enzyme residues Leu216 and Leu482.

Conclusions:

• The study reveals atomic-level differences in enzyme-substrate binding between CYP 3A4 and CYP 3A5.
• These findings provide a structural basis for understanding variations in drug metabolism and toxicity, supporting precision medicine approaches.